Anti-KIR2DL2(lirilumab biosimilar) mAb TA389607 CNY 2,250.00 2周 Anti-KIR2DL2(lirilumab biosimilar) mAb Applications FC Reactivities Human
United States
Germany
Japan
United Kingdom
China
